To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation
Clinical trial NCT00189319 · COMPLETED
Trial details
- NCT number
- NCT00189319
- Sponsor
- MEDA Pharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.